FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:400 February 9, 1995 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: In their editorial (Aug. 4 issue),¹ Drs. Landau and Geelhoed state that with corticosteroid treatment "intubated children can be extubated earlier." They refer to a report on a well-controlled study,² the senior author of which is Dr. Landau. Unfortunately, they fail to cite another well-controlled study,³ which came to the opposite conclusion. Thus, they give readers the impression that corticosteroid prophylaxis is the state of the art for pediatric extubation, whereas it is actually a controversial therapy. The Journal's editorials are highly respected sources of information on the state of the art and must represent the . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Alpsoy, E., Durusoy, C., Yilmaz, E., Ozgurel, Y., Ermis, O., Yazar, S., Basaran, E. (2002). Interferon Alfa-2a in the Treatment of Behcet Disease: A Randomized Placebo-Controlled and Double-blind Study. Arch Dermatol 138: 467-471 [Abstract] [Full Text]  
• Kötter, I., Eckstein, A. K, Stübiger, N., Zierhut, M. (1998). Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol 82: 488-494 [Abstract] [Full Text]